PKP2 and arrhythmogenic right ventricular cardiomyopathy: Comparison of GenDIRECT target lesions with the clinical ablation data in patients with inducible VT demonstrated excellent co-localization of the predicted with the clinical ablation lesions in ARVC patients undergoing index (first) ablation, regardless of the different patient genotypes (GE or PKP2).